Is Eli Lilly Heading Back to New Highs? Plus Lionsgate Looks to Tap the SPAC Market 1/9/24

Shares of Eli Lilly closed just off record highs as CEO David Ricks is set to make comments at the JP Morgan Health Care conference. Could what he says send the stock rocketing again? And will an Alzheimer’s treatment be its next big blockbuster? Plus Lionsgate set to spin off its studio business in a SPAC deal. Vice Chairman Michael Burns joins with the latest on that deal. Fast Money Disclaimer